Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer

Tommaso Susini1 Department of Health Science, Gynecology Section, University of Florence, ItalyCorrespondence[email protected]

Barbara Berti1 Department of Health Science, Gynecology Section, University of Florence, Italy

Carlo Carriero1 Department of Health Science, Gynecology Section, University of Florence, Italy

Ketty Tavella2 Department of Health Science, Chemotherapy Section, University of Florence, Italy

Jacopo Nori3 Diagnostic Senology Unit, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy

Ermanno Vanzi3 Diagnostic Senology Unit, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy

Cecilia Molino1 Department of Health Science, Gynecology Section, University of Florence, Italy

Mariarosaria Di Tommaso1 Department of Health Science, Gynecology Section, University of Florence, Italy

Marco Santini1 Department of Health Science, Gynecology Section, University of Florence, Italy

Valeria Saladino4 Department of Surgery and Translational Medicine, Pathology Unit, University of Florence, Italy

Simonetta Bianchi4 Department of Surgery and Translational Medicine, Pathology Unit, University of Florence, Italy

Articles from other publishers (9)